At the proteome level, TMA data of brain tumors from Tianjin Medical University General Hospital showed that Gal9 was enriched in GBM (Figure 2a,b) and Gal9 was more highly expressed in the core than in the border of tumors in GBM patients (Figure 2d–f). This evidence concerns the gene LGALS9 and glioblastoma.